1. Home
  2. HQL vs SOPH Comparison

HQL vs SOPH Comparison

Compare HQL & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo abrdn Life Sciences Investors Shares of Beneficial Interest

HQL

abrdn Life Sciences Investors Shares of Beneficial Interest

SELL

Current Price

$17.81

Market Cap

539.1M

Sector

Finance

ML Signal

SELL

Logo SOPHiA GENETICS SA

SOPH

SOPHiA GENETICS SA

SELL

Current Price

$7.43

Market Cap

462.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
HQL
SOPH
Founded
1992
2011
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
539.1M
462.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
HQL
SOPH
Price
$17.81
$7.43
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $9.75
AVG Volume (30 Days)
102.6K
★ 625.5K
Earning Date
01-01-0001
11-03-2026
Dividend Yield
★ 11.56%
N/A
EPS Growth
N/A
N/A
EPS
★ 0.79
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$23.68
Revenue Next Year
N/A
$24.29
P/E Ratio
$23.17
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.66
$3.83
52 Week High
$22.67
$8.98

Technical Indicators

Market Signals
Indicator
HQL
SOPH
Relative Strength Index (RSI) 44.90 50.58
Support Level $17.13 $4.58
Resistance Level $18.58 $7.94
Average True Range (ATR) 0.67 0.60
MACD 0.04 0.09
Stochastic Oscillator 26.26 67.29

Price Performance

Historical Comparison
HQL
SOPH

About HQL abrdn Life Sciences Investors Shares of Beneficial Interest

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Share on Social Networks: